Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 460

1.

Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide.

Trapella C, Fischetti C, Pela' M, Lazzari I, Guerrini R, Calo' G, Rizzi A, Camarda V, Lambert DG, McDonald J, Regoli D, Salvadori S.

Bioorg Med Chem. 2009 Jul 15;17(14):5080-95. doi: 10.1016/j.bmc.2009.05.068. Epub 2009 Jun 2.

PMID:
19527931
2.

Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24.

Fischetti C, Camarda V, Rizzi A, Pelà M, Trapella C, Guerrini R, McDonald J, Lambert DG, Salvadori S, Regoli D, Calo' G.

Eur J Pharmacol. 2009 Jul 1;614(1-3):50-7. doi: 10.1016/j.ejphar.2009.04.054. Epub 2009 May 12.

PMID:
19445927
3.

Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.

Spagnolo B, Carrà G, Fantin M, Fischetti C, Hebbes C, McDonald J, Barnes TA, Rizzi A, Trapella C, Fanton G, Morari M, Lambert DG, Regoli D, Calò G.

J Pharmacol Exp Ther. 2007 Jun;321(3):961-7. Epub 2007 Feb 28.

4.
5.

N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.

Guerrini R, Caló G, Lambert DG, Carrá G, Arduin M, Barnes TA, McDonald J, Rizzi D, Trapella C, Marzola E, Rowbotham DJ, Regoli D, Salvadori S.

J Med Chem. 2005 Mar 10;48(5):1421-7.

PMID:
15743186
6.

[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.

Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.

Br J Pharmacol. 2002 May;136(2):303-11.

7.

Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.

Bojnik E, Babos F, Fischetti C, Magyar A, Camarda V, Borsodi A, Bajusz S, Calo' G, Benyhe S.

Brain Res Bull. 2010 Mar 16;81(4-5):477-83. doi: 10.1016/j.brainresbull.2009.09.013. Epub 2009 Oct 2.

PMID:
19800951
8.

[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.

Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.

J Pharmacol Exp Ther. 2005 Mar;312(3):1114-23. Epub 2004 Oct 27.

9.

Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.

Fischetti C, Rizzi A, Gavioli EC, Marzola G, Trapella C, Guerrini R, Petersen JS, Calo G.

Peptides. 2009 Feb;30(2):248-55. doi: 10.1016/j.peptides.2008.10.001. Epub 2008 Oct 17.

PMID:
18992780
10.

Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.

Ibba M, Kitayama M, McDonald J, Calo G, Guerrini R, Farkas J, Toth G, Lambert DG.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Dec;378(6):553-61. doi: 10.1007/s00210-008-0350-3. Epub 2008 Sep 21.

PMID:
18807245
11.

Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice.

Rizzi A, Rizzi D, Marzola G, Regoli D, Larsen BD, Petersen JS, Calo' G.

Br J Pharmacol. 2002 Oct;137(3):369-74.

12.

In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.

Bigoni R, Calo' G, Rizzi A, Guerrini R, De Risi C, Hashimoto Y, Hashiba E, Lambert DG, Regoli D.

Naunyn Schmiedebergs Arch Pharmacol. 2000 May;361(5):565-8.

PMID:
10832612
13.

Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111.

Marti M, Mela F, Budri M, Volta M, Malfacini D, Molinari S, Zaveri NT, Ronzoni S, Petrillo P, Calò G, Morari M.

Br J Pharmacol. 2013 Feb;168(4):863-79. doi: 10.1111/j.1476-5381.2012.02219.x.

14.

In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.

Gündüz O, Rizzi A, Baldisserotto A, Guerrini R, Spagnolo B, Gavioli EC, Kocsis L, Magyar A, Benyhe S, Borsodi A, Calò G.

Eur J Pharmacol. 2006 Jun 6;539(1-2):39-48. Epub 2006 Apr 5.

PMID:
16682024
15.

Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.

Guerrini R, Carra' G, Calo' G, Trapella C, Marzola E, Rizzi D, Regoli D, Salvadori S.

J Pept Res. 2004 Jun;63(6):477-84.

PMID:
15175020
16.

Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.

Arduin M, Spagnolo B, Calò G, Guerrini R, Carrà G, Fischetti C, Trapella C, Marzola E, McDonald J, Lambert DG, Regoli D, Salvadori S.

Bioorg Med Chem. 2007 Jul 1;15(13):4434-43. Epub 2007 Apr 24.

PMID:
17490886
17.

Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.

Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):528-37. Epub 2003 Nov 4.

PMID:
14598020
18.
19.

Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4).

Volta M, Marti M, McDonald J, Molinari S, Camarda V, Pelà M, Trapella C, Morari M.

Peptides. 2010 Jun;31(6):1194-204. doi: 10.1016/j.peptides.2010.03.015. Epub 2010 Mar 20.

PMID:
20307605
20.

Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.

Rizzi A, Gavioli EC, Marzola G, Spagnolo B, Zucchini S, Ciccocioppo R, Trapella C, Regoli D, Calò G.

J Pharmacol Exp Ther. 2007 Jun;321(3):968-74. Epub 2007 Feb 28.

Items per page

Supplemental Content

Write to the Help Desk